Compare AGEN & QNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGEN | QNC |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.6M | 366.4M |
| IPO Year | 1999 | 2026 |
| Metric | AGEN | QNC |
|---|---|---|
| Price | $6.84 | $1.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $26.33 | N/A |
| AVG Volume (30 Days) | ★ 856.6K | 582.4K |
| Earning Date | 11-05-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $42,877,086.00 | N/A |
| Revenue This Year | $9.64 | $5,145.73 |
| Revenue Next Year | N/A | $505.80 |
| P/E Ratio | $7.35 | ★ N/A |
| Revenue Growth | ★ 89.95 | N/A |
| 52 Week Low | $2.71 | $1.01 |
| 52 Week High | $10.19 | $3.79 |
| Indicator | AGEN | QNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.89 | 30.98 |
| Support Level | $6.66 | N/A |
| Resistance Level | $8.64 | $2.26 |
| Average True Range (ATR) | 0.46 | 0.10 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 57.46 | 4.00 |
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.
Quantum eMotion Corp is a technology development company focused on developing and commercializing intellectual property in quantum-based cryptographic and cybersecurity solutions. The company delivers quantum-based security solutions in software and hardware that embed true quantum randomness at the chip level. Its software offerings include Sentry-Q for securing data across networks and applications; eFlux-Q, a cloud-based entropy distribution system for cryptographic systems and key generation; eCrypto-Q, a developer toolkit combining electron-based QRNG and post-quantum cryptography; and eHot-Q, a quantum-safe hot wallet SDK for digital asset protection. Its hardware solution includes eCore-Q, an electron-based QRNG providing high-speed entropy for cryptographic, AI, and IoT systems.